Chad Tang, MD, discusses potential roadblocks for the clinical use of metastasis-directed radiotherapy for patients with oligometastatic ccRCC.
Chad Tang, MD
Advertisement
Chad Tang, MD, is an associate professor in the Department of Radiation Oncology of the Division of Radiation Oncology; in the Department of Translational Molecular Pathology; and in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center in Houston.
Articles by Chad Tang, MD
Chad Tang, MD, discusses outcomes for metastasis-directed radiotherapy without systemic therapy in oligometastatic clear cell renal cell carcinoma.
Chad Tang, MD, discusses unanswered questions surrounding the role of radiation therapy in renal cell carcinoma.
Chad Tang, MD, discusses the potential role for radiation therapy in advanced renal cell carcinoma.
Advertisement
Latest Updated Articles
Dr Tang on Metastasis-Directed Radiotherapy Without Systemic Therapy in Oligometastatic ccRCCPublished: April 28th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5